Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances A Collichio

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Journal of Pain and Symptom Management|October 23, 2020
Mortality Risk for Patients With Stage IV Cancer and Acute Illness HospitalizationLaura C Hanson, Natalie C Ernecoff, Kathryn L Wessell, et al.
Practical Radiation Oncology|November 22, 2014
Unanticipated hospital admissions during or soon after radiation therapy: Incidence and predictive factorsMark R Waddle, Ronald C Chen, Nabeel H Arastu, et al.
Clinical Breast Cancer|December 15, 2010
Phase II study of bortezomib and pegylated liposomal doxorubicin in the treatment of metastatic breast cancerWilliam J Irvin, Robert Z Orlowski, Wing-Keung Chiu, et al.
Cancer Chemotherapy and Pharmacology|February 8, 2007
Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane) on three treatment schedules in patients with solid tumorsThomas E Stinchcombe, Mark A Socinski, Christine M Walko, et al.
Anti-Cancer Drugs|April 4, 2017
The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases: the potential impact of immunotherapyOrit Kaidar-Person, Timothy M Zagar, Allison Deal, et al.
Journal of Pain and Symptom Management|March 2, 2021
Pre-Post Evaluation of Collaborative Oncology Palliative Care for Patients With Stage IV CancerLaura C Hanson, Kathryn L Wessell, Jenny Hanspal, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|February 22, 2016
Medical Knowledge Assessment by Hematology and Medical Oncology In-Training Examinations Are Better Than Program Director Assessments at Predicting Subspecialty Certification Examination PerformanceFrances A Collichio, Brian J Hess, Elaine A Muchmore, et al.
Investigational New Drugs|November 12, 2017
A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanomaSandra P D'Angelo, Omid A Hamid, Ahmad Tarhini, et al.
Annals of Surgery|September 10, 2025
Anatomic Location Predicts Response Rates: Real World Outcomes With Over 1100 Cycles of Talimogene Laherparepvec Description: A Retrospective Review of a Prospectively Maintained DatabaseKristen E Dougherty, Gray B Peery, Chris B Agala, et al.
Journal for Immunotherapy of Cancer|May 4, 2023
Talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone for advanced melanoma: 5-year final analysis of a multicenter, randomized, open-label, phase II trialJason A Chesney, Igor Puzanov, Frances A Collichio, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Journal of Pain and Symptom Management|October 23, 2020
Mortality Risk for Patients With Stage IV Cancer and Acute Illness HospitalizationLaura C Hanson, Natalie C Ernecoff, Kathryn L Wessell, et al.
Practical Radiation Oncology|November 22, 2014
Unanticipated hospital admissions during or soon after radiation therapy: Incidence and predictive factorsMark R Waddle, Ronald C Chen, Nabeel H Arastu, et al.
Clinical Breast Cancer|December 15, 2010
Phase II study of bortezomib and pegylated liposomal doxorubicin in the treatment of metastatic breast cancerWilliam J Irvin, Robert Z Orlowski, Wing-Keung Chiu, et al.
Cancer Chemotherapy and Pharmacology|February 8, 2007
Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane) on three treatment schedules in patients with solid tumorsThomas E Stinchcombe, Mark A Socinski, Christine M Walko, et al.
Anti-Cancer Drugs|April 4, 2017
The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases: the potential impact of immunotherapyOrit Kaidar-Person, Timothy M Zagar, Allison Deal, et al.
Journal of Pain and Symptom Management|March 2, 2021
Pre-Post Evaluation of Collaborative Oncology Palliative Care for Patients With Stage IV CancerLaura C Hanson, Kathryn L Wessell, Jenny Hanspal, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|February 22, 2016
Medical Knowledge Assessment by Hematology and Medical Oncology In-Training Examinations Are Better Than Program Director Assessments at Predicting Subspecialty Certification Examination PerformanceFrances A Collichio, Brian J Hess, Elaine A Muchmore, et al.
Investigational New Drugs|November 12, 2017
A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanomaSandra P D'Angelo, Omid A Hamid, Ahmad Tarhini, et al.
Annals of Surgery|September 10, 2025
Anatomic Location Predicts Response Rates: Real World Outcomes With Over 1100 Cycles of Talimogene Laherparepvec Description: A Retrospective Review of a Prospectively Maintained DatabaseKristen E Dougherty, Gray B Peery, Chris B Agala, et al.
Journal for Immunotherapy of Cancer|May 4, 2023
Talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone for advanced melanoma: 5-year final analysis of a multicenter, randomized, open-label, phase II trialJason A Chesney, Igor Puzanov, Frances A Collichio, et al.
Pageof 5